Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited
600329
Hisse Senetlerindeki Sıralama
#4374
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited, along with its... Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited, along with its subsidiaries, primarily manufactures and markets traditional Chinese medicine, Western pharmaceuticals, and various healthcare products within the People's Republic of China. Its business activities are structured into two distinct divisions: Chinese Medicine and Western Medicine. The company's operations extend beyond its core offerings to include the production and distribution of Chinese, Western, and biological pharmaceutical items. It also engages in the wholesale and retail trade of medicines, biochemical pharmaceutical products, and everyday consumer goods, in addition to managing hospitals. Furthermore, Tianjin Pharmaceutical Da Ren Tang provides a comprehensive suite of services such as logistics, inventory management, equipment installation, and drug processing. It also offers pharmaceutical inspection, testing, and advisory services. In terms of its commercial model, the company supplies its proprietary branded medicinal products directly to wholesalers. Conversely, it acquires pharmaceuticals marketed under other brands from distributors, subsequently reselling these to other wholesale clients. Established in 1992 and based in Tianjin, People's Republic of China, the company was previously known as Tianjin Zhong Xin Pharmaceutical Group Corporation Limited before adopting its current name in May 2022.
Hisse Fiyatı
$6.17
Piyasa Değeri
$3.52B
Değişim (1 gün)
-0.05%
Değişim (1 yıl)
-1.86%
Ülke
CN
Ticaret Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited (600329)
Kategori
Healthcare
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited (600329) için kazanç
2026 itibarıyla kazanç TTM: 0
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited şirketinin en son finansal raporlarına göre, mevcut kazancı 0'dir. 2026 yılında şirket 0 kazanç elde etti, bu 2026 yılındaki 0 kazanca göre önceki yıla eşit. Bu sayfada gösterilen kazanç, faiz ve vergiler öncesi kazançtır; yani EBIT.
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited için kazanç geçmişi 2001 - 2026
Her yılın sonundaki kazanç
| Yıl | Kazanç | Değiştir |
|---|---|---|
| 2025 | $355.53M | 0.63% |
| 2024 | $353.30M | 128.32% |
| 2023 | $154.74M | 8.90% |
| 2022 | $142.10M | 3.48% |
| 2021 | $137.32M | 16.80% |
| 2020 | $117.57M | 10.16% |
| 2019 | $106.72M | 14.59% |
| 2018 | $93.13M | 14.11% |
| 2017 | $81.61M | 21.49% |
| 2016 | $67.18M | -18.79% |
| 2015 | $82.72M | 18.91% |
| 2014 | $69.56M | 1.17% |
| 2013 | $68.76M | -17.14% |
| 2012 | $82.98M | 85.74% |
| 2011 | $44.67M | -16.41% |
| 2010 | $53.45M | 42.73% |
| 2009 | $37.45M | 56.81% |
| 2008 | $23.88M | -711.08% |
| 2007 | $-3.91M | -92.20% |
| 2006 | $-50.07M | -485.02% |
| 2005 | $13.00M | 15.50% |
| 2004 | $11.26M | -23.83% |
| 2003 | $14.78M | 20.06% |
| 2002 | $12.31M | 20.70% |
| 2001 | $10.20M | 0.00% |
Benzer şirketler veya rakipler için kazanç
| Şirket | Kazanç | Kazanç Farkı | Ülke |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| $1.76B | - |
IN
|
